Français
ItalianoBond Teva Pharmaceutical Industries 2.4% ( US88165FAC68 ) in USD
| Issuer | Teva Pharmaceutical Industries | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  Israel
|
||||||
| ISIN code |
 US88165FAC68 ( in USD )
|
||||||
| Interest rate | 2.4% per year ( payment 2 times a year) | ||||||
| Maturity | 10/11/2016 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 950 000 000 USD | ||||||
| Cusip | 88165FAC6 | ||||||
| Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) | ||||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||||
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. The Bond issued by Teva Pharmaceutical Industries ( Israel ) , in USD, with the ISIN code US88165FAC68, pays a coupon of 2.4% per year. The coupons are paid 2 times per year and the Bond maturity is 10/11/2016 The Bond issued by Teva Pharmaceutical Industries ( Israel ) , in USD, with the ISIN code US88165FAC68, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Teva Pharmaceutical Industries ( Israel ) , in USD, with the ISIN code US88165FAC68, was rated BBB ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||
